Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-01-17 @ 8:12 AM
Study NCT ID:
NCT04830592
Status:
COMPLETED
Last Update Posted:
2025-03-24
First Post:
2021-03-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck
Sponsor:
Akamis Bio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-04
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-04
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-31
First Submit QC Date:
None
Study First Post Date:
2021-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-21
Last Update Post Date:
2025-03-24
Last Update Post Date Type:
ACTUAL